4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-096523
Chief Commercial Officer sold 148 shares at $14.90 ($2,205)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Friedl-Naderer Johanna · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-05 | Sale : show line 1 in the form 10b5-1 | −148 | $14.90 | $2,205 | 154,581 | D |
| Open-market sales · 148 sh · avg $14.90 · $2,205 | ||||||
Loading xslF345X05/ownership.xml…